ESOMEPRAZOLE MAGNESIUM | A207193 | PERRIGO R AND D CO
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ASTRAZENECA AB et al v. PERRIGO COMPANY PLC et al 2 patentsANDA 207193esomeprazole magnesium | D.N.J. | 2015-02-04 | Terminated 2017-06-09 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.3514
per ea
Lowest NADAC/Unit
$0.3514
per ea
Brand NDCs
0
Generic NDCs
12
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 70000072701ESOMEPRAZOLE MAG DR 20 MG CAP | $0.3514 | EA | Generic | — | 2026-06-17 |
| 70000072702ESOMEPRAZOLE MAG DR 20 MG CAP | $0.3514 | EA | Generic | — | 2026-06-17 |
| 00113089801GS ESOMEPRAZOLE MAG DR 20 MG | $0.3514 | EA | Generic | — | 2026-06-17 |
| 00113089802GS ESOMEPRAZOLE MAG DR 20 MG | $0.3514 | EA | Generic | — | 2026-06-17 |
| 00113089803GS ESOMEPRAZOLE MAG DR 20 MG | $0.3514 | EA | Generic | — | 2026-06-17 |
| 70677109901FT ACID REDUCER DR 20 MG CAP | $0.3514 | EA | Generic | — | 2026-06-17 |
Showing 6 of 12 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.